Free Trial

Nucor (NUE) Financials

Nucor logo
$250.76 +0.77 (+0.31%)
As of 12:44 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Nucor

Annual Income Statements for Nucor

This table shows Nucor's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
81 796 1,319 2,361 1,271 721 6,827 7,607 4,525 2,027 1,744
Consolidated Net Income / (Loss)
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Net Income / (Loss) Continuing Operations
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Total Pre-Tax Income
242 1,299 1,750 3,229 1,783 836 9,201 10,245 6,273 2,902 2,568
Total Operating Income
410 1,429 1,882 3,325 1,901 999 9,257 10,404 6,230 2,842 2,592
Total Gross Profit
1,114 2,026 2,569 4,295 2,679 2,228 11,025 12,503 7,815 4,102 3,878
Total Revenue
16,439 16,208 20,252 25,067 22,589 20,140 36,484 41,512 34,714 30,734 32,494
Operating Revenue
16,439 16,208 20,252 25,067 22,589 20,140 36,484 41,512 34,714 30,734 32,494
Total Cost of Revenue
15,325 14,182 17,683 20,772 19,910 17,912 25,459 29,009 26,899 26,632 28,616
Operating Cost of Revenue
15,325 14,182 17,683 20,772 19,910 17,912 25,459 29,009 26,899 26,632 28,616
Total Operating Expenses
704 597 688 971 778 1,229 1,769 2,099 1,585 1,260 1,286
Selling, General & Admin Expense
459 597 688 861 711 615 1,707 1,997 1,585 1,123 1,219
Impairment Charge
245 0.00 - 110 67 614 62 102 0.00 137 67
Total Other Income / (Expense), net
-168 -130 -132 -95 -118 -164 -56 -159 43 60 -24
Interest Expense
174 169 174 136 121 153 159 170 -30 -30 59
Interest & Investment Income
5.33 39 42 40 3.31 -11 103 11 13 30 35
Income Tax Expense
49 398 369 748 412 -0.49 2,078 2,166 1,360 583 530
Net Income / (Loss) Attributable to Noncontrolling Interest
112 104 62 120 100 115 295 472 388 292 294
Basic Earnings per Share
$0.25 $2.48 $4.11 $7.44 $4.14 $2.37 $23.23 $28.88 $18.05 $8.47 $7.53
Weighted Average Basic Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Diluted Earnings per Share
$0.25 $2.48 $4.10 $7.42 $4.14 $2.36 $23.16 $28.79 $18.00 $8.46 $7.52
Weighted Average Diluted Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Weighted Average Basic & Diluted Shares Outstanding
-93.90M 319.56M 319.99M 315.86M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Cash Dividends to Common per Share
$1.49 $1.50 $1.51 $3.08 $1.60 $1.61 $1.72 $2.01 $2.07 $2.17 $2.21

Quarterly Income Statements for Nucor

This table shows Nucor's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026
Net Income / (Loss) Attributable to Common Shareholders
1,142 786 845 645 250 287 156 603 607 378 743
Consolidated Net Income / (Loss)
1,221 873 959 712 303 345 226 706 683 423 870
Net Income / (Loss) Continuing Operations
1,221 873 959 712 303 345 226 706 683 423 870
Total Pre-Tax Income
1,548 1,078 1,225 898 389 390 285 899 883 501 1,096
Total Operating Income
1,535 1,038 1,178 886 391 387 295 908 888 501 1,108
Total Gross Profit
1,921 1,394 1,523 1,194 758 627 605 1,223 1,188 862 1,501
Total Revenue
8,776 7,705 8,137 8,077 7,444 7,076 7,830 8,456 8,521 7,687 9,496
Operating Revenue
8,776 7,705 8,137 8,077 7,444 7,076 7,830 8,456 8,521 7,687 9,496
Total Cost of Revenue
6,855 6,311 6,614 6,883 6,686 6,449 7,225 7,233 7,333 6,825 7,995
Operating Cost of Revenue
6,855 6,311 6,614 6,883 6,686 6,449 7,225 7,233 7,333 6,825 7,995
Total Operating Expenses
386 356 345 308 367 240 310 315 300 361 393
Selling, General & Admin Expense
386 356 345 294 244 226 281 304 300 334 378
Other Operating Expenses / (Income)
0.00 - 0.00 - - - 0.00 - - - 0.00
Impairment Charge
0.00 - 0.00 14 123 - 29 11 0.00 27 15
Total Other Income / (Expense), net
13 40 47 12 -2.00 3.11 -10 -9.00 -5.00 - -12
Interest Expense
-14 -31 -38 -2.00 7.00 2.81 14 19 15 11 19
Interest & Investment Income
-1.08 9.33 9.00 10 5.00 5.92 4.00 10 10 11 7.00
Income Tax Expense
327 205 266 186 86 45 59 193 200 78 226
Net Income / (Loss) Attributable to Noncontrolling Interest
80 87 114 67 53 58 70 103 76 45 127
Basic Earnings per Share
$4.58 $3.18 $3.46 $2.68 $1.05 $1.28 $0.67 $2.60 $2.63 $1.63 $3.23
Weighted Average Basic Shares Outstanding
248.50M 240.75M 243.10M 239.60M 236.50M 230.54M 232.70M 230.60M 229.90M 227.77M 228.90M
Diluted Earnings per Share
$4.57 $3.17 $3.46 $2.68 $1.05 $1.27 $0.67 $2.60 $2.63 $1.62 $3.23
Weighted Average Diluted Shares Outstanding
248.92M 240.75M 243.50M 240M 236.80M 230.54M 232.90M 230.80M 230.20M 227.77M 229.30M
Weighted Average Basic & Diluted Shares Outstanding
245.84M 240.75M 239.76M 237.34M 234.81M 230.54M 230.75M 229.54M 228.86M 227.77M 227.74M
Cash Dividends to Common per Share
$0.51 - $0.54 - - - $0.55 - - - $0.56

Annual Cash Flow Statements for Nucor

This table details how cash moves in and out of Nucor's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
663 106 -1,106 450 136 1,220 -246 1,852 2,026 -2,829 -1,298
Net Cash From Operating Activities
1,909 1,750 1,055 2,394 2,809 2,697 6,231 10,072 7,112 3,979 3,234
Net Cash From Continuing Operating Activities
1,909 1,750 1,055 2,394 2,809 2,697 6,231 10,072 7,112 3,979 3,234
Net Income / (Loss) Continuing Operations
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Consolidated Net Income / (Loss)
193 900 1,381 2,481 1,371 836 7,122 8,079 4,913 2,319 2,038
Depreciation Expense
626 613 636 631 649 702 735 827 931 1,094 1,226
Amortization Expense
74 74 91 89 86 83 129 235 238 262 254
Non-Cash Adjustments To Reconcile Net Income
40 58 72 173 191 709 95 285 151 264 191
Changes in Operating Assets and Liabilities, net
975 104 -1,124 -980 512 367 -1,851 646 879 40 -475
Net Cash From Investing Activities
-442 -1,025 -919 -1,030 -1,794 -1,764 -2,874 -5,703 -2,496 -3,734 -3,226
Net Cash From Continuing Investing Activities
-442 -1,025 -919 -1,030 -1,794 -1,764 -2,874 -5,703 -2,496 -3,734 -3,226
Purchase of Property, Plant & Equipment
-374 -605 -449 -983 -1,477 -1,543 -1,622 -1,948 -2,214 -3,173 -3,422
Acquisitions
-19 -475 -544 -33 -83 -88 -1,426 -3,553 -71 -758 -2.00
Purchase of Investments
-192 -713 -109 -121 -414 -533 -494 -914 -1,507 -1,296 -986
Sale of Property, Plant & Equipment
29 19 25 32 42 41 19 32 15 17 45
Divestitures
- 135 - 0.00 68 0.00 0.00 100 0.00 1.00 0.00
Sale and/or Maturity of Investments
111 600 150 50 68 392 649 590 1,317 1,487 1,140
Other Investing Activities, net
3.01 14 7.39 25 2.87 -33 0.40 -10 -36 -12 -1.00
Net Cash From Financing Activities
-804 -626 -1,242 -908 -880 286 -3,603 -2,511 -2,593 -3,058 -1,315
Net Cash From Continuing Financing Activities
-804 -626 -1,242 -908 -880 286 -3,603 -2,511 -2,593 -3,058 -1,315
Repayment of Debt
-18 -13 -603 -508 -9.13 -287 38 -1,195 -52 82 -1,112
Repurchase of Common Equity
-67 -5.17 -90 -862 -299 -46 -3,276 -2,776 -1,554 -2,217 -709
Payment of Dividends
-551 -581 -576 -542 -568 -607 -634 -866 -950 -874 -761
Issuance of Debt
-156 -33 35 1,001 4.57 1,233 197 2,092 0.00 0.00 1,217
Other Financing Activities, net
-12 -9.60 -14 -22 -8.90 -7.26 72 234 -37 -49 50
Effect of Exchange Rate Changes
- - - - - - -0.32 -6.00 3.00 -16 9.00

Quarterly Cash Flow Statements for Nucor

This table details how cash moves in and out of Nucor's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026
Net Change in Cash & Equivalents
1,346 518 -1,829 81 -376 -705 -402 -1,210 275 39 -34
Net Cash From Operating Activities
2,464 1,520 460 1,485 1,301 733 364 732 1,339 799 886
Net Cash From Continuing Operating Activities
2,464 1,520 460 1,477 1,309 733 364 732 1,339 799 886
Net Income / (Loss) Continuing Operations
1,221 873 959 712 303 345 226 706 683 423 870
Consolidated Net Income / (Loss)
1,221 873 959 712 303 345 226 706 683 423 870
Depreciation Expense
232 250 257 271 281 285 303 303 304 316 321
Amortization Expense
58 62 59 61 69 73 65 63 63 63 63
Non-Cash Adjustments To Reconcile Net Income
19 35 19 45 171 29 40 50 14 87 44
Changes in Operating Assets and Liabilities, net
933 300 -834 388 484 1.58 -270 -390 275 -90 -412
Net Cash From Investing Activities
-461 -655 -890 -711 -1,170 -964 -1,180 -543 -786 -717 -446
Net Cash From Continuing Investing Activities
-461 -655 -890 -703 -1,178 -964 -1,180 -543 -786 -717 -446
Purchase of Property, Plant & Equipment
-439 -718 -670 -801 -823 -879 -859 -954 -807 -802 -661
Acquisitions
- -71 1.00 -110 -563 -86 -1.00 - 1.00 -2.00 0.00
Purchase of Investments
-499 -272 -647 -240 -150 -259 -452 -215 -206 -113 -143
Sale of Property, Plant & Equipment
3.33 6.38 4.00 5.09 2.30 5.17 3.00 36 3.00 3.00 14
Divestitures
- - 0.00 - - -0.44 0.00 - - - 0.00
Sale and/or Maturity of Investments
508 400 422 434 354 277 127 590 221 202 326
Other Investing Activities, net
-35 -1.00 0.00 9.20 0.41 -22 2.00 - 2.00 -5.00 18
Net Cash From Financing Activities
-655 -349 -1,396 -692 -510 -461 414 -1,410 -273 -46 -472
Net Cash From Continuing Financing Activities
-655 -349 -1,396 -692 -510 -461 414 -1,410 -273 -46 -472
Repayment of Debt
-6.64 -32 -7.00 -17 -3.65 98 -48 -942 -97 -25 1.00
Repurchase of Common Equity
-500 -177 -1,001 -500 -400 -315 -309 -200 -100 -100 -125
Payment of Dividends
-152 -150 -399 -181 -148 -147 -301 -171 -144 -145 -349
Issuance of Debt
2.60 13 11 49 45 -95 997 -68 68 220 0.00
Other Financing Activities, net
0.89 -2.89 0.00 -44 -3.20 -2.14 75 -29 - 4.00 1.00
Other Net Changes in Cash
-2.63 - -3.00 - 2.59 - - - - - -2.00

Annual Balance Sheets for Nucor

This table presents Nucor's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
14,327 15,224 15,841 17,921 18,345 20,125 25,823 32,479 35,340 33,940 35,104
Total Current Assets
5,854 6,506 6,824 8,636 8,226 9,489 12,800 14,692 16,386 12,475 11,765
Cash & Equivalents
1,939 2,046 949 1,399 1,535 2,640 2,365 4,281 6,383 3,558 2,260
Restricted Cash
- - - - 0.00 - - 80 4.00 - 0.00
Short-Term Investments
100 150 50 0.00 300 408 253 577 747 581 439
Accounts Receivable
1,384 1,632 2,029 2,506 2,160 2,299 3,854 3,591 2,953 2,675 3,105
Inventories, net
2,245 2,480 3,462 4,554 3,842 3,569 6,011 5,454 5,578 5,106 5,462
Other Current Assets
186 199 335 178 390 573 317 789 725 555 499
Plant, Property, & Equipment, net
4,891 5,079 5,093 5,335 6,179 6,899 8,115 9,617 11,050 13,243 15,306
Total Noncurrent Assets
3,581 3,638 3,924 3,950 3,940 3,738 4,909 8,090 7,900 8,222 8,033
Goodwill
2,011 2,053 2,196 2,184 2,201 2,230 2,827 3,920 3,969 4,288 4,297
Intangible Assets
771 867 915 829 742 668 1,104 3,322 3,108 3,134 2,880
Other Noncurrent Operating Assets
799 719 813 937 996 840 978 848 823 800 856
Total Liabilities & Shareholders' Equity
14,327 15,224 15,841 17,921 18,345 20,125 25,823 32,479 35,340 33,940 35,104
Total Liabilities
6,477 6,969 6,756 7,719 7,553 8,894 11,219 12,909 13,217 12,523 12,980
Total Current Liabilities
1,385 2,390 2,825 2,806 2,464 2,628 5,157 4,330 4,595 4,977 4,004
Short-Term Debt
51 618 553 58 92 69 723 78 193 1,267 212
Accounts Payable
567 838 1,181 1,428 1,202 1,432 1,974 1,650 2,020 1,832 1,890
Accrued Expenses
478 505 574 611 660 664 965 948 1,056 975 1,020
Current Employee Benefit Liabilities
289 429 517 709 511 463 1,495 1,654 1,326 903 882
Total Noncurrent Liabilities
5,092 4,579 3,932 4,912 5,090 6,266 6,062 8,580 8,622 7,546 8,976
Long-Term Debt
4,337 3,739 3,242 4,233 4,291 5,272 4,961 6,614 6,649 5,683 6,909
Noncurrent Deferred & Payable Income Tax Liabilities
755 840 689 679 798 994 1,100 1,966 1,973 1,863 2,067
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
7,850 8,255 9,085 10,202 10,791 11,232 14,604 19,570 22,123 21,417 22,124
Total Preferred & Common Equity
7,478 7,880 8,739 9,792 10,358 10,789 14,016 18,415 20,940 20,294 20,936
Total Common Equity
7,478 7,880 8,739 9,792 10,358 10,789 14,016 18,415 20,940 20,294 20,936
Common Stock
2,070 2,126 2,173 2,226 2,260 2,273 2,293 2,296 2,328 2,375 2,405
Retained Earnings
7,317 7,631 8,464 10,337 11,115 11,344 17,674 24,755 28,762 30,271 31,504
Accumulated Other Comprehensive Income / (Loss)
-351 -318 -255 -304 -303 -119 -115 -138 -162 -208 -194
Other Equity Adjustments
- - - - - - - - - - -12,779
Noncontrolling Interest
372 375 346 410 433 443 587 1,155 1,183 1,123 1,188

Quarterly Balance Sheets for Nucor

This table presents Nucor's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 4/1/2023 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 4/4/2026
Total Assets
32,246 34,268 35,340 33,933 34,185 34,346 33,940 34,699 34,217 34,776 35,635
Total Current Assets
14,316 15,949 16,386 14,643 14,258 13,521 12,475 12,760 11,719 11,808 12,088
Cash & Equivalents
3,800 5,856 6,383 4,558 4,639 4,263 3,558 3,156 1,946 2,221 2,226
Restricted Cash
- 13 4.00 0.05 0.00 0.00 0.00 0.00 0.00 - 0.00
Short-Term Investments
818 863 747 981 795 596 581 905 537 524 255
Accounts Receivable
3,662 3,428 2,953 3,157 3,113 2,949 2,675 2,965 3,388 3,288 3,567
Inventories, net
5,591 5,246 5,578 5,590 5,256 5,126 5,106 5,256 5,462 5,393 5,644
Other Current Assets
446 556 725 357 455 587 555 478 386 382 396
Plant, Property, & Equipment, net
9,863 10,356 11,050 11,457 11,999 12,580 13,243 13,759 14,303 14,821 15,596
Total Noncurrent Assets
8,067 7,950 7,900 7,833 7,928 8,245 8,222 8,180 8,195 8,147 7,951
Goodwill
3,915 3,922 3,969 3,956 4,000 4,274 4,288 4,287 4,299 4,294 4,295
Intangible Assets
3,263 3,147 3,108 3,049 3,051 3,194 3,134 3,069 3,006 2,943 2,817
Other Noncurrent Operating Assets
889 881 823 828 876 777 800 824 890 910 839
Total Liabilities & Shareholders' Equity
32,246 34,268 35,340 33,933 34,185 34,346 33,940 34,699 34,217 34,776 35,635
Total Liabilities
12,317 12,759 13,217 12,207 12,413 12,790 12,523 13,584 12,725 12,845 13,087
Total Current Liabilities
3,830 4,284 4,595 3,646 4,865 5,217 4,977 5,059 4,146 4,257 4,167
Short-Term Debt
54 61 193 204 1,244 1,254 1,267 1,191 189 167 247
Accounts Payable
2,012 1,855 2,020 1,616 1,745 1,903 1,832 2,272 2,183 2,145 2,109
Accrued Expenses
1,004 1,099 1,056 1,140 1,019 1,085 975 1,022 1,029 1,046 1,110
Current Employee Benefit Liabilities
759 1,269 1,326 686 857 975 903 574 745 899 701
Total Noncurrent Liabilities
8,487 8,475 8,622 8,561 7,547 7,573 7,546 8,525 8,579 8,588 8,920
Long-Term Debt
6,616 6,621 6,649 6,648 5,649 5,685 5,683 6,689 6,692 6,686 6,877
Noncurrent Deferred & Payable Income Tax Liabilities
1,870 1,854 1,973 1,913 1,899 1,888 1,863 1,836 1,887 1,902 2,043
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
19,930 21,509 22,123 21,726 21,773 21,557 21,417 21,115 21,492 21,931 22,548
Total Preferred & Common Equity
19,017 20,466 20,940 20,694 20,724 20,473 20,294 20,069 20,389 20,770 21,453
Total Common Equity
19,017 20,466 20,940 20,694 20,724 20,473 20,294 20,069 20,389 20,770 21,453
Common Stock
2,321 2,318 2,328 2,363 2,341 2,360 2,375 2,397 2,365 2,385 2,426
Retained Earnings
25,762 28,110 28,762 29,476 29,992 30,114 30,271 30,300 30,775 31,255 32,118
Accumulated Other Comprehensive Income / (Loss)
-165 -149 -162 -177 -178 -168 -208 -198 -167 -189 -206
Other Equity Adjustments
-8,900 -9,813 - -10,968 -11,432 -11,833 - -12,430 -12,584 -12,681 -12,885
Noncontrolling Interest
912 1,043 1,183 1,032 1,049 1,084 1,123 1,046 1,103 1,161 1,095

Annual Metrics And Ratios for Nucor

This table displays calculated financial ratios and metrics derived from Nucor's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-22.11% -1.41% 24.95% 23.77% -9.89% -10.84% 81.15% 13.78% -16.38% -11.47% 5.73%
EBITDA Growth
-45.25% 90.63% 23.28% 55.02% -34.83% -32.28% 467.10% 13.29% -35.47% -43.26% -3.00%
EBIT Growth
-68.53% 248.51% 31.68% 76.67% -42.82% -47.43% 826.34% 12.39% -40.12% -54.38% -8.80%
NOPAT Growth
-62.99% 202.77% 49.83% 72.05% -42.77% -31.60% 616.66% 14.50% -40.53% -53.46% -9.42%
Net Income Growth
-75.21% 366.46% 53.33% 79.71% -44.75% -39.02% 751.93% 13.43% -39.19% -52.80% -12.12%
EPS Growth
-88.15% 892.00% 65.32% 80.98% -44.20% -43.00% 881.36% 24.31% -37.48% -53.00% -11.11%
Operating Cash Flow Growth
51.04% -8.32% -39.70% 126.84% 17.35% -4.01% 131.04% 61.65% -29.39% -44.05% -18.72%
Free Cash Flow Firm Growth
958.99% -53.49% -97.45% 6,695.14% -9.28% -33.03% 270.67% 50.75% -3.97% -102.88% -107.19%
Invested Capital Growth
-11.59% 2.13% 14.06% 10.21% 1.87% 1.39% 30.65% 20.67% 2.38% 10.98% 9.57%
Revenue Q/Q Growth
-8.60% 3.18% 5.94% 5.04% -4.90% 0.64% 16.27% -3.80% -2.85% -2.01% 1.92%
EBITDA Q/Q Growth
-40.28% 49.11% 2.96% 15.58% -20.59% 2.83% 38.32% -10.82% -6.44% -12.60% 3.43%
EBIT Q/Q Growth
-64.35% 95.52% 3.58% 19.84% -26.83% 4.63% 42.48% -12.14% -7.90% -18.65% 4.60%
NOPAT Q/Q Growth
-61.09% 98.55% 18.48% 12.18% -27.18% 53.06% 35.76% -10.71% -9.56% -18.02% 4.06%
Net Income Q/Q Growth
-73.16% 121.29% 18.95% 13.03% -28.51% 53.56% 36.76% -11.16% -8.45% -18.54% 3.98%
EPS Q/Q Growth
-86.49% 169.57% 20.59% 13.11% -29.23% 67.38% 38.52% -8.83% -9.00% -18.34% 4.88%
Operating Cash Flow Q/Q Growth
-9.72% 33.66% -23.13% 9.30% 7.53% -6.84% 51.54% -0.76% -12.47% -16.51% 2.08%
Free Cash Flow Firm Q/Q Growth
17.86% -10.24% 107.75% -1.48% -2.37% -16.70% 374.79% -0.36% -29.07% -121.28% 38.61%
Invested Capital Q/Q Growth
-2.56% 3.09% 2.32% 4.52% 0.38% 4.32% 0.36% -4.06% 1.74% 2.50% 1.95%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
6.78% 12.50% 12.69% 17.14% 11.86% 11.06% 30.22% 30.12% 22.51% 13.35% 11.93%
EBITDA Margin
6.75% 13.06% 12.88% 16.13% 11.67% 8.86% 27.74% 27.62% 21.31% 13.66% 12.53%
Operating Margin
2.49% 8.82% 9.29% 13.26% 8.42% 4.96% 25.37% 25.06% 17.95% 9.25% 7.98%
EBIT Margin
2.49% 8.82% 9.29% 13.26% 8.42% 4.96% 25.37% 25.06% 17.95% 9.25% 7.98%
Profit (Net Income) Margin
1.17% 5.56% 6.82% 9.90% 6.07% 4.15% 19.52% 19.46% 14.15% 7.55% 6.27%
Tax Burden Percent
79.81% 69.33% 78.89% 76.83% 76.90% 100.06% 77.41% 78.86% 78.32% 79.91% 79.36%
Interest Burden Percent
58.98% 90.87% 92.99% 97.13% 93.79% 83.61% 99.40% 98.47% 100.69% 102.11% 99.07%
Effective Tax Rate
20.19% 30.67% 21.11% 23.17% 23.10% -0.06% 22.59% 21.14% 21.68% 20.09% 20.64%
Return on Invested Capital (ROIC)
3.01% 9.61% 13.32% 20.45% 11.06% 7.44% 45.94% 42.08% 22.61% 9.86% 8.10%
ROIC Less NNEP Spread (ROIC-NNEP)
-1.61% 5.60% 9.12% 17.88% 7.72% 0.68% 44.33% 36.88% 27.22% 13.67% 7.58%
Return on Net Nonoperating Assets (RNNOA)
-0.59% 1.57% 2.61% 5.27% 2.00% 0.15% 9.20% 5.20% 0.95% 0.79% 1.26%
Return on Equity (ROE)
2.42% 11.18% 15.92% 25.73% 13.06% 7.59% 55.14% 47.28% 23.57% 10.65% 9.36%
Cash Return on Invested Capital (CROIC)
15.31% 7.51% 0.18% 10.74% 9.20% 6.06% 19.36% 23.35% 20.26% -0.55% -1.03%
Operating Return on Assets (OROA)
2.74% 9.67% 12.12% 19.69% 10.48% 5.20% 40.29% 35.69% 18.37% 8.20% 7.51%
Return on Assets (ROA)
1.29% 6.09% 8.89% 14.70% 7.56% 4.35% 31.00% 27.71% 14.49% 6.69% 5.90%
Return on Common Equity (ROCE)
2.32% 10.66% 15.26% 24.72% 12.54% 7.29% 52.94% 44.87% 22.25% 10.09% 8.86%
Return on Equity Simple (ROE_SIMPLE)
2.58% 11.43% 15.80% 25.34% 13.24% 7.75% 50.81% 43.87% 23.46% 11.43% 0.00%
Net Operating Profit after Tax (NOPAT)
327 991 1,485 2,554 1,462 1,000 7,166 8,204 4,879 2,271 2,057
NOPAT Margin
1.99% 6.11% 7.33% 10.19% 6.47% 4.96% 19.64% 19.76% 14.06% 7.39% 6.33%
Net Nonoperating Expense Percent (NNEP)
4.62% 4.01% 4.20% 2.57% 3.34% 6.77% 1.61% 5.20% -4.61% -3.81% 0.53%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 31.24% 16.85% 8.01% 7.03%
Cost of Revenue to Revenue
93.22% 87.50% 87.31% 82.86% 88.14% 88.94% 69.78% 69.88% 77.49% 86.65% 88.07%
SG&A Expenses to Revenue
2.79% 3.68% 3.39% 3.43% 3.15% 3.05% 4.68% 4.81% 4.57% 3.65% 3.75%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.28% 3.68% 3.39% 3.87% 3.44% 6.10% 4.85% 5.06% 4.57% 4.10% 3.96%
Earnings before Interest and Taxes (EBIT)
410 1,429 1,882 3,325 1,901 999 9,257 10,404 6,230 2,842 2,592
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,110 2,116 2,609 4,044 2,636 1,785 10,121 11,466 7,399 4,198 4,072
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.41 2.03 2.00 1.48 1.51 1.42 2.25 1.79 2.01 1.35 1.78
Price to Tangible Book Value (P/TBV)
2.25 3.23 3.11 2.13 2.11 1.94 3.13 2.94 3.04 2.13 2.71
Price to Revenue (P/Rev)
0.64 0.99 0.86 0.58 0.69 0.76 0.87 0.79 1.21 0.89 1.15
Price to Earnings (P/E)
130.72 20.10 13.28 6.12 12.29 21.18 4.63 4.32 9.32 13.52 21.40
Dividend Yield
4.52% 2.99% 2.75% 3.34% 3.11% 3.19% 1.55% 1.57% 1.21% 1.86% 1.35%
Earnings Yield
0.77% 4.98% 7.53% 16.33% 8.14% 4.72% 21.61% 23.12% 10.73% 7.40% 4.67%
Enterprise Value to Invested Capital (EV/IC)
1.30 1.78 1.74 1.36 1.39 1.33 1.99 1.68 1.97 1.29 1.62
Enterprise Value to Revenue (EV/Rev)
0.81 1.14 1.02 0.71 0.82 0.89 0.97 0.86 1.24 1.02 1.32
Enterprise Value to EBITDA (EV/EBITDA)
11.96 8.76 7.91 4.39 7.06 10.09 3.48 3.12 5.82 7.47 10.55
Enterprise Value to EBIT (EV/EBIT)
32.37 12.97 10.97 5.34 9.79 18.03 3.81 3.44 6.91 11.03 16.57
Enterprise Value to NOPAT (EV/NOPAT)
40.56 18.71 13.91 6.95 12.73 18.02 4.92 4.36 8.82 13.80 20.87
Enterprise Value to Operating Cash Flow (EV/OCF)
6.95 10.59 19.57 7.42 6.62 6.68 5.66 3.55 6.05 7.88 13.28
Enterprise Value to Free Cash Flow (EV/FCFF)
7.98 23.95 1,046.45 13.25 15.29 22.11 11.67 7.87 9.85 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.53 0.42 0.42 0.41 0.48 0.39 0.34 0.31 0.32 0.32
Long-Term Debt to Equity
0.55 0.45 0.36 0.41 0.40 0.47 0.34 0.34 0.30 0.27 0.31
Financial Leverage
0.36 0.28 0.29 0.29 0.26 0.22 0.21 0.14 0.04 0.06 0.17
Leverage Ratio
1.88 1.83 1.79 1.75 1.73 1.75 1.78 1.71 1.63 1.59 1.59
Compound Leverage Factor
1.11 1.67 1.67 1.70 1.62 1.46 1.77 1.68 1.64 1.62 1.57
Debt to Total Capital
35.86% 34.55% 29.47% 29.61% 28.88% 32.23% 28.02% 25.48% 23.62% 24.50% 24.35%
Short-Term Debt to Total Capital
0.42% 4.90% 4.29% 0.40% 0.60% 0.42% 3.57% 0.30% 0.67% 4.47% 0.72%
Long-Term Debt to Total Capital
35.44% 29.65% 25.17% 29.21% 28.28% 31.81% 24.45% 25.18% 22.96% 20.03% 23.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.04% 2.97% 2.68% 2.83% 2.86% 2.67% 2.90% 4.40% 4.08% 3.96% 4.06%
Common Equity to Total Capital
61.10% 62.48% 67.85% 67.56% 68.26% 65.10% 69.09% 70.12% 72.29% 71.54% 71.59%
Debt to EBITDA
3.95 2.06 1.45 1.06 1.66 2.99 0.56 0.58 0.92 1.66 1.75
Net Debt to EBITDA
2.12 1.02 1.07 0.72 0.97 1.28 0.30 0.15 -0.04 0.67 1.09
Long-Term Debt to EBITDA
3.91 1.77 1.24 1.05 1.63 2.95 0.49 0.58 0.90 1.35 1.70
Debt to NOPAT
13.41 4.40 2.56 1.68 3.00 5.34 0.79 0.82 1.40 3.06 3.46
Net Debt to NOPAT
7.18 2.18 1.88 1.13 1.74 2.29 0.43 0.21 -0.06 1.24 2.15
Long-Term Debt to NOPAT
13.25 3.77 2.18 1.66 2.94 5.27 0.69 0.81 1.36 2.50 3.36
Altman Z-Score
3.31 3.78 4.28 4.33 4.04 3.39 5.60 5.31 5.02 4.01 4.42
Noncontrolling Interest Sharing Ratio
4.24% 4.64% 4.16% 3.92% 4.02% 3.98% 3.99% 5.10% 5.61% 5.30% 5.31%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.23 2.72 2.42 3.08 3.34 3.61 2.48 3.39 3.57 2.51 2.94
Quick Ratio
2.47 1.60 1.07 1.39 1.62 2.03 1.25 1.95 2.19 1.37 1.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,664 774 20 1,341 1,216 815 3,020 4,552 4,371 -126 -261
Operating Cash Flow to CapEx
553.70% 298.50% 249.35% 251.75% 195.69% 179.52% 388.79% 525.68% 323.42% 126.08% 95.77%
Free Cash Flow to Firm to Interest Expense
9.59 4.57 0.11 9.89 10.02 5.32 19.01 26.78 0.00 0.00 -4.42
Operating Cash Flow to Interest Expense
11.00 10.34 6.08 17.66 23.14 17.60 39.22 59.25 0.00 0.00 54.81
Operating Cash Flow Less CapEx to Interest Expense
9.01 6.88 3.64 10.65 11.31 7.80 29.13 47.98 0.00 0.00 -2.42
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.10 1.10 1.30 1.48 1.25 1.05 1.59 1.42 1.02 0.89 0.94
Accounts Receivable Turnover
9.52 10.75 11.07 11.06 9.68 9.03 11.86 11.15 10.61 10.92 11.24
Inventory Turnover
6.14 6.00 5.95 5.18 4.74 4.83 5.31 5.06 4.88 4.99 5.42
Fixed Asset Turnover
3.23 3.25 3.98 4.81 3.92 3.08 4.86 4.68 3.36 2.53 2.28
Accounts Payable Turnover
19.64 20.19 17.51 15.92 15.14 13.60 14.95 16.01 14.66 13.83 15.38
Days Sales Outstanding (DSO)
38.32 33.95 32.98 33.01 37.69 40.41 30.78 32.73 34.40 33.42 32.46
Days Inventory Outstanding (DIO)
59.43 60.81 61.32 70.42 76.96 75.51 68.68 72.13 74.85 73.21 67.40
Days Payable Outstanding (DPO)
18.58 18.08 20.84 22.93 24.11 26.84 24.42 22.80 24.90 26.40 23.74
Cash Conversion Cycle (CCC)
79.17 76.69 73.46 80.50 90.55 89.08 75.04 82.06 84.35 80.24 76.12
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
10,199 10,416 11,881 13,094 13,340 13,525 17,671 21,323 21,831 24,228 26,546
Invested Capital Turnover
1.51 1.57 1.82 2.01 1.71 1.50 2.34 2.13 1.61 1.33 1.28
Increase / (Decrease) in Invested Capital
-1,337 217 1,465 1,213 245 185 4,146 3,652 508 2,397 2,318
Enterprise Value (EV)
13,274 18,538 20,649 17,761 18,601 18,014 35,246 35,805 43,055 31,339 42,939
Market Capitalization
10,553 16,002 17,507 14,459 15,619 15,278 31,592 32,897 42,164 27,405 37,329
Book Value per Share
$23.40 $24.74 $27.49 $31.19 $34.16 $35.73 $49.04 $71.78 $85.18 $86.43 $91.48
Tangible Book Value per Share
$14.69 $15.57 $17.70 $21.59 $24.45 $26.14 $35.29 $43.55 $56.39 $54.82 $60.12
Total Capital
12,238 12,612 12,880 14,493 15,174 16,572 20,289 26,261 28,965 28,367 29,245
Total Debt
4,388 4,357 3,795 4,291 4,383 5,341 5,685 6,691 6,842 6,950 7,121
Total Long-Term Debt
4,337 3,739 3,242 4,233 4,291 5,272 4,961 6,614 6,649 5,683 6,909
Net Debt
2,349 2,161 2,796 2,892 2,548 2,293 3,067 1,753 -292 2,811 4,422
Capital Expenditures (CapEx)
345 586 423 951 1,436 1,502 1,603 1,916 2,199 3,156 3,377
Debt-free, Cash-free Net Working Capital (DFCFNWC)
2,481 2,538 3,553 4,489 4,020 3,882 5,748 5,501 4,850 4,626 5,274
Debt-free Net Working Capital (DFNWC)
4,521 4,734 4,552 5,888 5,854 6,930 8,366 10,440 11,984 8,765 7,973
Net Working Capital (NWC)
4,469 4,116 4,000 5,830 5,763 6,861 7,642 10,362 11,791 7,498 7,761
Net Nonoperating Expense (NNE)
134 90 104 73 91 164 43 125 -34 -48 19
Net Nonoperating Obligations (NNO)
2,349 2,161 2,796 2,892 2,548 2,293 3,067 1,753 -292 2,811 4,422
Total Depreciation and Amortization (D&A)
700 687 727 720 735 785 865 1,062 1,169 1,356 1,480
Debt-free, Cash-free Net Working Capital to Revenue
15.09% 15.66% 17.55% 17.91% 17.79% 19.28% 15.75% 13.25% 13.97% 15.05% 16.23%
Debt-free Net Working Capital to Revenue
27.50% 29.21% 22.48% 23.49% 25.92% 34.41% 22.93% 25.15% 34.52% 28.52% 24.54%
Net Working Capital to Revenue
27.19% 25.40% 19.75% 23.26% 25.51% 34.07% 20.95% 24.96% 33.97% 24.40% 23.88%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.11 $2.48 $4.11 $7.44 $4.14 $2.37 $23.23 $28.88 $18.05 $8.47 $7.53
Adjusted Weighted Average Basic Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Adjusted Diluted Earnings per Share
$1.11 $2.48 $4.10 $7.42 $4.14 $2.36 $23.16 $28.79 $18.00 $8.46 $7.52
Adjusted Weighted Average Diluted Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
317.94M 318.85M 317.94M 305.38M 301.00M 298.05M 269.12M 251.93M 240.75M 230.54M 227.77M
Normalized Net Operating Profit after Tax (NOPAT)
523 991 1,485 2,639 1,513 1,129 7,214 8,285 4,879 2,381 2,110
Normalized NOPAT Margin
3.18% 6.11% 7.33% 10.53% 6.70% 5.61% 19.77% 19.96% 14.06% 7.75% 6.49%
Pre Tax Income Margin
1.47% 8.01% 8.64% 12.88% 7.89% 4.15% 25.22% 24.68% 18.07% 9.44% 7.90%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.36 8.44 10.84 24.53 15.66 6.52 58.27 61.20 0.00 0.00 43.93
NOPAT to Interest Expense
1.89 5.85 8.55 18.85 12.04 6.53 45.11 48.26 0.00 0.00 34.87
EBIT Less CapEx to Interest Expense
0.38 4.98 8.40 17.51 3.83 -3.28 48.18 49.93 0.00 0.00 -13.31
NOPAT Less CapEx to Interest Expense
-0.10 2.39 6.11 11.83 0.21 -3.28 35.02 36.99 0.00 0.00 -22.37
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
285.64% 64.49% 41.74% 21.83% 41.46% 72.62% 8.90% 10.72% 19.34% 37.69% 37.34%
Augmented Payout Ratio
320.09% 65.06% 48.28% 56.56% 63.24% 78.10% 54.90% 45.08% 50.97% 133.29% 72.13%

Quarterly Metrics And Ratios for Nucor

This table displays calculated financial ratios and metrics derived from Nucor's official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/30/2024 6/29/2024 9/28/2024 12/31/2024 4/5/2025 7/5/2025 10/4/2025 12/31/2025 4/4/2026
DEI Shares Outstanding
- - - - - - - - - - 227,740,950.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 227,740,950.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 3.26
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-16.43% -11.67% -6.58% -15.18% -15.17% -8.17% -3.77% 4.69% 14.47% 8.63% 21.28%
EBITDA Growth
-31.02% -27.40% -20.91% -47.80% -59.43% -44.82% -55.62% 4.60% 69.37% 18.12% 125.04%
EBIT Growth
-34.87% -33.97% -26.77% -56.70% -74.58% -62.72% -74.96% 2.48% 127.11% 29.46% 275.59%
NOPAT Growth
-33.66% -38.15% -25.70% -55.66% -74.86% -59.28% -74.63% 1.51% 125.53% 23.56% 275.98%
Net Income Growth
-32.12% -34.14% -22.14% -55.13% -75.20% -60.47% -76.43% -0.84% 125.41% 22.61% 284.96%
EPS Growth
-29.69% -35.96% -22.25% -53.87% -77.02% -59.94% -80.64% -2.99% 150.48% 27.56% 382.09%
Operating Cash Flow Growth
-12.15% -39.99% -61.92% -22.66% -47.21% -51.76% -20.87% -50.71% 2.92% 9.00% 143.41%
Free Cash Flow Firm Growth
170.81% 114.51% 93.44% -192.57% -194.72% -717.46% -1,151.48% 91.36% 8.49% 7.77% 17.12%
Invested Capital Growth
-3.45% 2.38% 4.80% 0.00% 10.15% 10.98% 8.23% 11.45% 10.16% 9.57% 9.05%
Revenue Q/Q Growth
-7.85% -12.20% 0.00% -0.74% -7.84% -4.95% 10.66% 7.99% 0.77% -9.79% 23.53%
EBITDA Q/Q Growth
-21.79% -26.03% 0.00% -18.40% -39.22% 0.60% -11.03% 92.16% -1.49% -29.88% 69.55%
EBIT Q/Q Growth
-25.06% -32.35% 0.00% -24.70% -55.99% -0.81% -23.79% 207.80% -2.20% -43.58% 121.16%
NOPAT Q/Q Growth
-23.64% -30.58% 0.00% -23.71% -56.71% 12.46% -31.66% 204.82% -3.67% -38.42% 107.93%
Net Income Q/Q Growth
-23.05% -28.51% 0.00% -25.74% -57.48% 13.95% -34.51% 212.39% -3.26% -38.07% 105.67%
EPS Q/Q Growth
-21.34% -30.63% 0.00% -22.54% -60.82% 20.95% -47.24% 288.06% 1.15% -38.40% 99.38%
Operating Cash Flow Q/Q Growth
28.31% -38.30% -69.77% 223.13% -12.43% -43.62% -50.37% 101.10% 82.92% -40.33% 10.89%
Free Cash Flow Firm Q/Q Growth
-91.87% -83.18% 0.00% -16,803.54% 91.68% -9.63% 19.11% -17.10% 11.89% -10.50% 27.31%
Invested Capital Q/Q Growth
0.00% 1.74% 0.00% 0.84% 1.75% 2.50% 2.91% 3.83% 0.58% 1.95% 2.43%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
21.89% 18.10% 18.72% 14.78% 10.18% 8.86% 7.73% 14.46% 13.94% 11.21% 15.81%
EBITDA Margin
20.81% 17.53% 18.35% 15.09% 9.95% 10.53% 8.47% 15.07% 14.73% 11.45% 15.71%
Operating Margin
17.49% 13.48% 14.47% 10.98% 5.24% 5.47% 3.77% 10.74% 10.42% 6.52% 11.67%
EBIT Margin
17.49% 13.48% 14.47% 10.98% 5.24% 5.47% 3.77% 10.74% 10.42% 6.52% 11.67%
Profit (Net Income) Margin
13.92% 11.33% 11.79% 8.82% 4.07% 4.88% 2.89% 8.35% 8.02% 5.50% 9.16%
Tax Burden Percent
78.89% 80.96% 78.26% 79.29% 77.99% 88.43% 79.30% 78.53% 77.35% 84.43% 79.38%
Interest Burden Percent
100.85% 103.85% 104.04% 101.28% 99.49% 100.80% 96.61% 99.01% 99.44% 100.00% 98.92%
Effective Tax Rate
21.11% 19.04% 21.74% 20.71% 22.01% 11.57% 20.70% 21.47% 22.65% 15.57% 20.62%
Return on Invested Capital (ROIC)
22.57% 17.55% 17.18% 24.50% 5.69% 6.46% 3.79% 10.58% 10.35% 7.04% 12.14%
ROIC Less NNEP Spread (ROIC-NNEP)
24.24% 21.98% 19.39% 25.74% 5.53% 6.68% 3.48% 10.34% 10.22% 7.04% 11.91%
Return on Net Nonoperating Assets (RNNOA)
0.71% 0.77% 1.57% 1.72% 0.26% 0.39% 0.42% 1.40% 1.45% 1.17% 2.31%
Return on Equity (ROE)
23.28% 18.32% 18.75% 26.23% 5.95% 6.84% 4.21% 11.98% 11.80% 8.21% 14.45%
Cash Return on Invested Capital (CROIC)
28.22% 20.26% 15.57% -168.34% 2.62% -0.55% -1.30% -4.34% -1.71% -1.03% 1.71%
Operating Return on Assets (OROA)
18.48% 13.80% 14.93% 10.50% 4.79% 4.85% 3.34% 9.67% 9.61% 6.13% 11.33%
Return on Assets (ROA)
14.70% 11.60% 12.16% 8.43% 3.72% 4.33% 2.56% 7.52% 7.39% 5.18% 8.90%
Return on Common Equity (ROCE)
22.17% 17.30% 17.87% 24.96% 5.65% 6.48% 4.00% 11.38% 11.19% 7.78% 13.74%
Return on Equity Simple (ROE_SIMPLE)
26.22% 0.00% 22.42% 18.17% 13.91% 0.00% 7.90% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
1,211 841 922 703 304 342 234 713 687 423 880
NOPAT Margin
13.80% 10.91% 11.33% 8.71% 4.09% 4.84% 2.99% 8.43% 8.06% 5.50% 9.26%
Net Nonoperating Expense Percent (NNEP)
-1.67% -4.43% -2.21% -1.23% 0.15% -0.22% 0.31% 0.24% 0.13% 0.00% 0.23%
Return On Investment Capital (ROIC_SIMPLE)
- 2.90% - - - 1.21% 0.81% 2.51% 2.39% 1.45% 2.96%
Cost of Revenue to Revenue
78.11% 81.90% 81.28% 85.22% 89.82% 91.14% 92.27% 85.54% 86.06% 88.79% 84.19%
SG&A Expenses to Revenue
4.40% 4.62% 4.24% 3.80% 3.29% 3.19% 3.59% 3.60% 3.52% 4.35% 3.98%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
4.40% 4.62% 4.24% 3.80% 4.94% 3.39% 3.96% 3.73% 3.52% 4.70% 4.14%
Earnings before Interest and Taxes (EBIT)
1,535 1,038 1,178 887 390 387 295 908 888 501 1,108
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,826 1,351 1,493 1,219 741 745 663 1,274 1,255 880 1,492
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.88 2.01 2.35 1.83 1.74 1.35 1.19 1.56 1.53 1.78 1.83
Price to Tangible Book Value (P/TBV)
2.87 3.04 3.55 2.77 2.74 2.13 1.87 2.43 2.34 2.71 2.74
Price to Revenue (P/Rev)
1.07 1.21 1.43 1.16 1.14 0.89 0.78 1.03 0.99 1.15 1.15
Price to Earnings (P/E)
7.69 9.32 11.49 11.09 14.11 13.52 17.78 24.55 19.17 21.40 16.85
Dividend Yield
1.32% 1.21% 1.06% 1.35% 1.44% 1.86% 2.11% 1.59% 1.59% 1.35% 1.29%
Earnings Yield
13.01% 10.73% 8.70% 9.02% 7.09% 7.40% 5.62% 4.07% 5.22% 4.67% 5.93%
Enterprise Value to Invested Capital (EV/IC)
1.84 1.97 2.21 1.74 1.64 1.29 1.15 1.44 1.42 1.62 1.66
Enterprise Value to Revenue (EV/Rev)
1.10 1.24 1.49 1.24 1.24 1.02 0.94 1.21 1.16 1.32 1.32
Enterprise Value to EBITDA (EV/EBITDA)
4.98 5.82 7.28 6.86 8.08 7.47 8.51 10.90 9.39 10.55 9.19
Enterprise Value to EBIT (EV/EBIT)
5.82 6.91 8.79 8.71 11.10 11.03 14.63 18.84 14.91 16.57 13.22
Enterprise Value to NOPAT (EV/NOPAT)
7.30 8.82 11.18 10.99 14.00 13.80 18.10 23.40 18.69 20.87 16.66
Enterprise Value to Operating Cash Flow (EV/OCF)
4.85 6.05 8.01 6.82 8.14 7.88 7.38 11.92 11.66 13.28 11.99
Enterprise Value to Free Cash Flow (EV/FCFF)
6.39 9.85 14.55 0.00 65.55 0.00 0.00 0.00 0.00 0.00 101.02
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.31 0.31 0.32 0.32 0.32 0.32 0.37 0.32 0.31 0.32 0.32
Long-Term Debt to Equity
0.31 0.30 0.31 0.26 0.26 0.27 0.32 0.31 0.30 0.31 0.31
Financial Leverage
0.03 0.04 0.08 0.07 0.05 0.06 0.12 0.14 0.14 0.17 0.19
Leverage Ratio
1.59 1.63 1.59 1.57 1.59 1.59 1.60 1.58 1.59 1.59 1.61
Compound Leverage Factor
1.61 1.69 1.65 1.59 1.59 1.60 1.55 1.57 1.58 1.59 1.59
Debt to Total Capital
23.70% 23.62% 23.98% 24.04% 24.35% 24.50% 27.18% 24.25% 23.81% 24.35% 24.01%
Short-Term Debt to Total Capital
0.22% 0.67% 0.71% 4.34% 4.40% 4.47% 4.11% 0.67% 0.58% 0.72% 0.83%
Long-Term Debt to Total Capital
23.49% 22.96% 23.26% 19.71% 19.95% 20.03% 23.07% 23.59% 23.23% 23.62% 23.18%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
3.70% 4.08% 3.61% 3.66% 3.80% 3.96% 3.61% 3.89% 4.03% 4.06% 3.69%
Common Equity to Total Capital
72.60% 72.29% 72.41% 72.30% 71.85% 71.54% 69.22% 71.86% 72.16% 71.59% 72.30%
Debt to EBITDA
0.84 0.92 0.98 1.17 1.44 1.66 2.34 2.01 1.74 1.75 1.45
Net Debt to EBITDA
-0.01 -0.04 0.19 0.25 0.43 0.67 1.13 1.28 1.04 1.09 0.95
Long-Term Debt to EBITDA
0.84 0.90 0.95 0.96 1.18 1.35 1.99 1.96 1.70 1.70 1.40
Debt to NOPAT
1.24 1.40 1.50 1.87 2.50 3.06 4.98 4.32 3.47 3.46 2.64
Net Debt to NOPAT
-0.01 -0.06 0.29 0.40 0.75 1.24 2.41 2.76 2.08 2.15 1.72
Long-Term Debt to NOPAT
1.23 1.36 1.46 1.54 2.05 2.50 4.22 4.20 3.38 3.36 2.54
Altman Z-Score
4.55 4.53 5.12 4.43 4.14 3.77 3.44 4.01 4.00 4.22 4.39
Noncontrolling Interest Sharing Ratio
4.78% 5.61% 4.67% 4.82% 4.94% 5.30% 4.85% 4.97% 5.16% 5.31% 4.90%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.72 3.57 4.02 2.93 2.59 2.51 2.52 2.83 2.77 2.94 2.90
Quick Ratio
2.37 2.19 2.39 1.76 1.50 1.37 1.39 1.42 1.42 1.45 1.45
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
1,979 333 -133 -22,527 -1,874 -2,055 -1,662 -1,946 -1,715 -1,895 -1,377
Operating Cash Flow to CapEx
565.36% 213.73% 69.03% 186.64% 158.56% 83.91% 42.52% 79.74% 166.54% 100.00% 136.94%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 -257.37 -730.94 -118.72 -102.44 -114.33 -172.27 -72.50
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 178.62 260.89 26.00 38.53 89.27 72.64 46.63
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 65.97 -50.02 -35.14 -9.79 35.67 0.00 12.58
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.06 1.02 1.03 0.96 0.91 0.89 0.89 0.90 0.92 0.94 0.97
Accounts Receivable Turnover
9.79 10.61 10.01 10.50 9.84 10.92 9.94 9.48 10.22 11.24 10.46
Inventory Turnover
5.00 4.88 4.79 5.07 5.11 4.99 5.02 5.15 5.37 5.42 5.39
Fixed Asset Turnover
3.49 3.36 3.20 2.72 2.73 2.53 2.41 2.34 2.33 2.28 2.33
Accounts Payable Turnover
14.67 14.66 14.77 15.28 14.10 13.83 14.01 14.05 13.95 15.38 13.42
Days Sales Outstanding (DSO)
37.30 34.40 36.45 34.75 37.11 33.42 36.72 38.51 35.70 32.46 34.90
Days Inventory Outstanding (DIO)
72.95 74.85 76.13 71.95 71.45 73.21 72.65 70.89 67.98 67.40 67.69
Days Payable Outstanding (DPO)
24.88 24.90 24.71 23.88 25.88 26.40 26.05 25.98 26.16 23.74 27.21
Cash Conversion Cycle (CCC)
85.37 84.35 87.88 82.82 82.67 80.24 83.33 83.42 77.52 76.12 75.38
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
21,459 21,831 23,038 23,231 23,637 24,228 24,934 25,890 26,039 26,546 27,191
Invested Capital Turnover
1.64 1.61 1.52 2.81 1.39 1.33 1.27 1.25 1.28 1.28 1.31
Increase / (Decrease) in Invested Capital
-768 508 1,055 23,231 2,179 2,397 1,896 2,659 2,402 2,318 2,257
Enterprise Value (EV)
39,382 43,055 50,996 40,409 38,796 31,339 28,661 37,315 36,954 42,939 45,020
Market Capitalization
38,389 42,164 48,652 37,902 35,632 27,405 23,796 31,814 31,685 37,329 39,282
Book Value per Share
$82.28 $85.18 $85.13 $86.43 $86.26 $86.43 $87.05 $88.36 $90.49 $91.48 $94.19
Tangible Book Value per Share
$53.86 $56.39 $56.31 $57.02 $54.80 $54.82 $55.15 $56.70 $58.96 $60.12 $62.96
Total Capital
28,191 28,965 28,577 28,665 28,496 28,367 28,995 28,373 28,784 29,245 29,672
Total Debt
6,681 6,842 6,851 6,892 6,939 6,950 7,880 6,881 6,853 7,121 7,124
Total Long-Term Debt
6,621 6,649 6,648 5,649 5,685 5,683 6,689 6,692 6,686 6,909 6,877
Net Debt
-50 -292 1,312 1,458 2,081 2,811 3,819 4,398 4,108 4,422 4,643
Capital Expenditures (CapEx)
436 711 666 796 820 874 856 918 804 799 647
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,994 4,850 5,662 5,202 4,700 4,626 4,831 5,279 4,973 5,274 5,687
Debt-free Net Working Capital (DFNWC)
11,726 11,984 11,201 10,637 9,559 8,765 8,892 7,762 7,718 7,973 8,168
Net Working Capital (NWC)
11,665 11,791 10,997 9,393 8,304 7,498 7,701 7,573 7,551 7,761 7,921
Net Nonoperating Expense (NNE)
-10 -32 -37 -8.99 1.56 -2.75 7.93 7.07 3.87 0.00 9.53
Net Nonoperating Obligations (NNO)
-50 -292 1,312 1,458 2,081 2,811 3,819 4,398 4,108 4,422 4,643
Total Depreciation and Amortization (D&A)
291 312 316 332 350 358 368 366 367 379 384
Debt-free, Cash-free Net Working Capital to Revenue
13.98% 13.97% 16.58% 15.91% 14.99% 15.05% 15.88% 17.14% 15.60% 16.23% 16.65%
Debt-free Net Working Capital to Revenue
32.82% 34.52% 32.81% 32.53% 30.48% 28.52% 29.22% 25.20% 24.21% 24.54% 23.91%
Net Working Capital to Revenue
32.65% 33.97% 32.21% 28.73% 26.48% 24.40% 25.31% 24.58% 23.68% 23.88% 23.19%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$4.58 $3.18 $3.46 $2.68 $1.05 $1.28 $0.67 $2.60 $2.63 $1.63 $3.23
Adjusted Weighted Average Basic Shares Outstanding
248.50M 240.75M 243.10M 239.58M 236.46M 230.54M 232.70M 230.60M 229.90M 227.77M 228.90M
Adjusted Diluted Earnings per Share
$4.57 $3.17 $3.46 $2.68 $1.05 $1.27 $0.67 $2.60 $2.63 $1.62 $3.23
Adjusted Weighted Average Diluted Shares Outstanding
248.92M 240.75M 243.50M 239.94M 236.77M 230.54M 232.90M 230.80M 230.20M 227.77M 229.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
245.84M 240.75M 239.76M 237.34M 234.81M 230.54M 230.75M 229.54M 228.86M 227.77M 227.74M
Normalized Net Operating Profit after Tax (NOPAT)
1,211 841 922 703 400 342 257 722 687 446 891
Normalized NOPAT Margin
13.80% 10.91% 11.33% 8.71% 5.38% 4.84% 3.28% 8.53% 8.06% 5.80% 9.39%
Pre Tax Income Margin
17.64% 14.00% 15.06% 11.12% 5.22% 5.52% 3.64% 10.63% 10.36% 6.52% 11.54%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 53.59 137.71 21.07 47.79 59.20 45.55 58.32
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 41.80 121.78 16.71 37.53 45.79 38.45 46.29
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -59.06 -173.20 -40.07 -0.53 5.60 -27.09 24.26
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 -70.85 -189.13 -44.43 -10.79 -7.81 -34.18 12.24
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
17.92% 19.34% 18.97% 23.38% 30.79% 37.69% 48.93% 48.54% 38.93% 37.34% 30.16%
Augmented Payout Ratio
51.07% 50.97% 64.86% 81.24% 103.81% 133.29% 145.08% 126.08% 86.12% 72.13% 49.74%

Financials Breakdown Chart

Key Financial Trends

Nucor’s latest quarter shows solid profitability, but the year-over-year trend points to a cooler operating environment than the company enjoyed in 2024. In Q1 2026, revenue rose to $9.50 billion from $7.69 billion in Q4 2025 and $7.83 billion in Q1 2025, while net income attributable to common shareholders increased to $743 million. However, margins remain below the strongest levels seen over the last four years, and cash flow from operations softened compared with the prior-year quarters that benefited from stronger earnings and working-capital support.

  • Revenue rebounded sharply quarter over quarter. Q1 2026 revenue of $9.50 billion was up meaningfully from Q4 2025’s $7.69 billion, suggesting better shipment or pricing conditions.
  • Gross profit improved versus the immediately prior quarter. Gross profit rose to $1.50 billion in Q1 2026 from $862 million in Q4 2025.
  • Operating income was strong. Nucor posted $1.11 billion in operating income in Q1 2026, a healthy result for a cyclical steel producer.
  • Cash and short-term liquidity remain ample. The company ended Q1 2026 with $2.23 billion in cash and equivalents plus $255 million in short-term investments.
  • Retained earnings continue to build over time. Retained earnings increased to $32.1 billion in Q1 2026 from $30.3 billion a year earlier, reflecting the company’s long history of profitability.
  • Dividend remains part of the capital return story. Nucor paid $0.56 per share in dividends in Q1 2026, showing ongoing shareholder returns.
  • Capex stayed elevated but manageable. The company spent $661 million on property, plant and equipment in Q1 2026, consistent with ongoing investment in the business.
  • Debt levels are fairly steady. Long-term debt was $6.88 billion at the end of Q1 2026, only modestly higher than recent quarters.
  • Margins are below the strongest prior-year levels. Q1 2026 gross margin was about 15.8%, well below the stronger periods in 2023 and early 2024 when margins were materially higher.
  • Operating cash flow fell from the strongest recent quarters. Q1 2026 operating cash flow of $886 million was lower than Q3 2025’s $1.34 billion and Q2 2025’s $732 million.

Longer-term trend: Nucor’s four-year history shows a highly cyclical business. Results peaked in 2022 and parts of 2023, when revenue, operating income, and EPS were much stronger, then normalized through 2024 and 2025. The company has remained profitable throughout the cycle, which is a positive, but recent quarters show pressure from lower margins, higher inventory levels at times, and heavier capital spending. Still, the balance sheet remains solid and liquidity looks adequate for a cyclical downturn.

Bottom line: Nucor still looks financially resilient, but investors should view the recent quarter as a good operational result against a tougher backdrop, not as a return to peak-cycle strength. The company’s profitability, cash generation, and balance sheet are constructive, while margin compression and softening cash conversion are the main risks to watch.

06/01/26 10:05 AM ETAI Generated. May Contain Errors.

Nucor Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Nucor's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Nucor's net income appears to be on an upward trend, with a most recent value of $2.04 billion in 2025, rising from $193.03 million in 2015. The previous period was $2.32 billion in 2024. See where experts think Nucor is headed by visiting Nucor's forecast page.

Nucor's total operating income in 2025 was $2.59 billion, based on the following breakdown:
  • Total Gross Profit: $3.88 billion
  • Total Operating Expenses: $1.29 billion

Over the last 10 years, Nucor's total revenue changed from $16.44 billion in 2015 to $32.49 billion in 2025, a change of 97.7%.

Nucor's total liabilities were at $12.98 billion at the end of 2025, a 3.6% increase from 2024, and a 100.4% increase since 2015.

In the past 10 years, Nucor's cash and equivalents has ranged from $949.10 million in 2017 to $6.38 billion in 2023, and is currently $2.26 billion as of their latest financial filing in 2025.

Over the last 10 years, Nucor's book value per share changed from 23.40 in 2015 to 91.48 in 2025, a change of 291.0%.



Financial statements for NYSE:NUE last updated on 5/17/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners